SQI Diagnostics
In Brief This Week: Meridian Bioscience, SQI Diagnostics, Applied DNA, Abbott, Danaher, More
News items for the week of Feb. 6, 2023.
In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More
News items for the week of May 23, 2022.
In Brief This Week: Foundation Medicine, Seegene, SQI Diagnostics, Yourgene, More
News items for the week of Feb. 14, 2022.
SQI to Acquire Precision Biomonitoring SARS-CoV-2 Testing Business, Technology
The deal includes the Canadian distribution rights to Biomeme's SARS-CoV-2 Real-Time RT-PCR Test, as well as Precision's TripleLock diagnostic technology.
NEW YORK (GenomeWeb) – Toronto-based SQI Diagnostics continues to see its CustomPlex diagnostic tools and services business generate revenue as interest in its technology from pharmaceutical industry partners increases.
Aug 12, 2014
Apr 10, 2014
SQI Diagnostics Raises $3.8M in Public Offering
Feb 24, 2014
Canada Clears SQI Test for Celiac Disease
Oct 1, 2013
May 21, 2013
SQI's Q2 Revenues Drop to Zero
May 3, 2013
SQI Closes $3.8M Private Placement
Feb 15, 2013
SQI Diagnostics' Q1 Revenues Slide 25 Percent
Dec 14, 2012
No Revenues in Q4 for SQI Diagnostics
Nov 19, 2012
SQI Diagnostics May Seek Merger or Sale
Oct 16, 2012
Aug 28, 2012
Aug 22, 2012
No Revenues in Q3 for SQI
May 31, 2012
SQI Narrows Q2 Loss to $1.3M
May 18, 2012